Biomedical applications of collagen

Abraham, 2000, Evaluation of the porcine intestinal collagen layer as a biomaterial, J. Biomed. Mater. Res., 51, 442, 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.0.CO;2-4 Aebischer, 1996, Intrathecal delivery of CNTF using encapsulated genetically modified xenogenic cells in amyotrophic lateral sclerosis, Nat. Med., 2, 696, 10.1038/nm0696-696 Al-Hendy, 1996, Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts — an alternative approach to somatic gene therapy, Hum. Gene Ther., 6, 165, 10.1089/hum.1995.6.2-165 Angella, 2000, Enhanced short-term plasmid transfection of filtration surgery tissues, Invest. Ophthalmol. Vis. Sci., 41, 4158 Aquavella, 1988, Use of collagen shields as a surgical adjunct, J. Cataract Refractive Surg., 14, 492, 10.1016/S0886-3350(88)80004-X Assil, 1992, Efficacy of tobramycin — soaked collagen shield vs. tobramycin eyedrop loaden dose for sustained experimental Pseudomonas aeruginosa induced keratitis in rabbits, Am. J. Ophthalmol., 113, 418, 10.1016/S0002-9394(14)76165-3 Auger, 1998, Tissue-engineered human skin substitutes developed from collagen populated hydrated gels: clinical and fundamental applications, Med. Biol. Eng. Comput., 36, 801, 10.1007/BF02518887 Bank, 2000, The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation, Arthritis Rheum., 43, 2202, 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E Barbani, 1995, Bioartificial materials based on collagen: 1. Collagen cross-linking with gaseous glutaraldehyde, J. Biomater. Sci. Polym. Ed., 7, 461, 10.1163/156856295X00535 Barr, 1991, Systemic delivery of recombinant proteins by genetically modified myoblasts, Science, 254, 1507, 10.1126/science.1962212 Baziuk, 1992, Collagen shields and intraocular drug delivery: concentration of gentamicin in the aqueous and vitreous of a rabbit eye after lensectomy and vitrectomy, Int. Ophthalmol., 16, 101, 10.1007/BF00918940 Bell, 1983, The reconstitution of living skin, J. Invest. Dermatol., 81, 2, 10.1111/1523-1747.ep12539993 Bender, 1996, Efficiency of nanoparticles as a carrier system for antiviral agents in human monocytes/macrophages in vitro, Antimicrob. Agents Chemother., 40, 1467, 10.1128/AAC.40.6.1467 Bergeon, 1967, Collagen: a review, J. Okla State Med. Assoc., 60, 330 Berthold, 1998, Collagen microparticles: carriers for glucocorticosteroids, Eur. J. Pharm. Biopharm., 45, 23, 10.1016/S0939-6411(97)00119-7 Bloomfield, 1978, Soluble gentamycin ophthalmic inserts as a drug delivery system, Arch. Ophthalmol., 96, 885, 10.1001/archopht.1978.03910050487020 Boyce, 1998, Skin substitutes from cultured cells and collagen-GAG polymers, Med. Biol. Eng. Comput., 36, 791, 10.1007/BF02518886 Boyce, 1988, Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes, J. Biomed. Mater. Res., 22, 939, 10.1002/jbm.820221008 Boyce, 1992, Biotinylation of implantable collagen for drug delivery, J. Biomed. Mater. Res., 26, 547, 10.1002/jbm.820260410 Boyce, 1993, Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds, Antimicrob. Agents Chemother., 37, 1890, 10.1128/AAC.37.9.1890 Boyce, 1995, Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns, Ann. Surg., 222, 743, 10.1097/00000658-199512000-00008 Bradley, 1977, Some mechanical property considerations of reconstituted collagen for drug release supports, Biomater. Med. Dev. Artif. Organs, 5, 159, 10.3109/10731197709118671 Brauker, 1995, Immunoisolation in somatic cell gene therapy, J. Cell. Biochem., 21B, D1 Browder, 1986, Use of absorbable collagen for hemostasis in general surgical patients, Am. Surg., 52, 492 Burge, 1964, The structure and function of connective and skeletal tissue, 2 Cameron, 1978, A new topical hemostatic agent in gynecological surgery, Obstet. Gynecol., 51, 118 Carrol, 1989, Surgical Catgut: the myth of allergy, J. Hand Surg., 14B, 218, 10.1016/0266-7681(89)90131-9 Cascone, 1995, Blends of synthetic and natural polymers as drug delivery systems for growth hormone, Biomaterials, 16, 569, 10.1016/0142-9612(95)91131-H Chen, 1990, Cyclosporin-containing collagen shields suppress corneal allograft rejection, Am. J. Ophtalmol., 109, 132, 10.1016/S0002-9394(14)75976-8 Chen, 1995, Three dimensional energy-minimized model of human type II smith collagen microfibrill, J. Biomol. Struct. Dyn., 12, 1129, 10.1080/07391102.1995.10508804 Chevallay, 2000, Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy, Med. Biol. Eng. Comput., 38, 211, 10.1007/BF02344779 Chvapil, 1985, Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research, Am. J. Obstet. Gynecol., 151, 325, 10.1016/0002-9378(85)90296-0 Chvapil, 1993, Collagen fibers as a temporary scaffold for replacement of ACL in goats, J. Biomed. Mater. Res., 27, 313, 10.1002/jbm.820270305 Clarke, 1996, Intestine submucosa and polypropylene mesh for abdominal wall repair in dogs, J. Surg. Res., 60, 107, 10.1006/jsre.1996.0018 Cochran, 2000, Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans, J. Periodontol., 71, 1241, 10.1902/jop.2000.71.8.1241 Coester, 2000, Gelatin nanoparticles by two step desolvation, a new preparation method, surface modifications and cell uptake, J. Microencapsulation, 17, 187, 10.1080/026520400288427 Danielsen, 1990, Age-related thermal stability and susceptibility to proteolysis of rat bone collagen, Biochem. J., 272, 697, 10.1042/bj2720697 Deatherage, 1987, Packaging and delivery of bone induction factors in a collagenous implant, Collagen Rel. Res., 7, 225, 10.1016/S0174-173X(87)80012-2 Desgrandchamps, 2000, Biomaterials in functional reconstruction, Curr. Opin. Urol., 10, 201, 10.1097/00042307-200005000-00003 Doillon, 1986, Collagen — based wound dressing effects of hyaluronic acid and fibronectin on wound healing, Biomaterials, 7, 3, 10.1016/0142-9612(86)90080-3 Dorigo, 1995, Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics, Chemotherapy, 41, 1, 10.1159/000239317 Dorr, 1982, In vitro retinoid binding and release from a collagen sponge material in a simulated intravaginal environment, J. Biomed. Mater. Res., 16, 839, 10.1002/jbm.820160609 El-Samaligy, 1983, Reconstituted collagen nanoparticles, a novel drug carrier delivery system, J. Pharm. Pharmacol., 35, 537, 10.1111/j.2042-7158.1983.tb04831.x Farrugia, 1999, Gelatin behavior in dilute aqueous solution: designing a nanoparticulate formulation, J. Pharm. Pharmacol., 51, 643, 10.1211/0022357991772925 Fell, 1970, Determination of tablet strength by diametrical compression test, J. Pharm. Sci., 69, 688, 10.1002/jps.2600590523 Ferkol, 1993, Gene transfer into respiratory epithelial cells by targetting the polymeric immunoglobulin receptor, J. Clin. Invest., 92, 2394, 10.1172/JCI116845 Finkelstein, 1991, Further evaluation of collagen shields as a delivery sytem for 5-fluoruracil: histopathological observations, Can. J. Ophthalmol., 26, 129 Fonseca, 1996, Coating liposomes with collagen (Mr 50 000) increases uptake into liver, Biochim. Biophys. Acta, 1279, 259, 10.1016/0005-2736(95)00265-0 Friedberg, 1991, Device drug delivery to the eye, Ophthalmology, 98, 725, 10.1016/S0161-6420(91)32227-9 Friess, 1998, Collagen-biomaterial for drug delivery, Eur. J. Pharm. Biopharm., 45, 113, 10.1016/S0939-6411(98)00017-4 Fujioka, 1995, Novel delivery system for proteins using collagen as a carrier material: the minipellet, J. Contr. Release, 33, 307, 10.1016/0168-3659(94)00107-6 Fujioka, 1998, Protein release from collagen matrices, Adv. Drug. Del. Rev., 31, 247, 10.1016/S0169-409X(97)00119-1 Gebhardt, 1995, Collagen as a delivery system for hydrophobic drugs: studies with cyclosporinee, J. Ocul. Pharmacol. Ther., 11, 319, 10.1089/jop.1995.11.319 Geesin, 1996, Development of a skin model based on insoluble fibrillar collagen, J. Biomed. Mater. Res., 33, 1, 10.1002/(SICI)1097-4636(199621)33:1<1::AID-JBM1>3.0.CO;2-W Girton, 2000, Mechanisms of stiffening and strengthening in media equivalents fabricated using glycation, J. Biomech. Eng., 122, 216, 10.1115/1.429652 Gloeckner, 2000, Mechanical evaluation and design of a multilayered collagenous repair, Biomaterial, 52, 365 Gorham, 1992, Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking, Int. J. Biol. Macromol., 14, 129, 10.1016/S0141-8130(05)80002-9 Grammer, 1996, Impregnation of collagen corneal shields with liposomes: uptake and release of hydrophilic and lipophilic marker substances, Curr. Eye Res., 15, 815, 10.3109/02713689609017622 Gross, 1963, 5, 307 Gussler, 1990, Collagen shield delivery of trifluorothymidine, J. Cataract Refractive Surg., 16, 719, 10.1016/S0886-3350(13)81013-9 Harkness, 1961, Biological functions of collagen, Biol. Rev., 36, 399, 10.1111/j.1469-185X.1961.tb01596.x Harkness, 1966, Collagen, Sci. Prog. Oxf., 54, 257 Harriger, 1997, Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice, J. Biomed. Mater. Res., 35, 137, 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O Harrison, 1989, Collagen corneal shields — an important therapeutic modality, J. Ophthal. Nurs. Technol., 8, 97 Heartlein, 1994, Long-term production and delivery of human growth hormone in vivo, Proc. Natl. Acad. Sci. USA, 91, 10967, 10.1073/pnas.91.23.10967 Hobden, 1988, Treatment of experimental pseudomonas keratitis using collagen shields containing tobramycin, Arch. Ophthalmol., 106, 1605, 10.1001/archopht.1988.01060140773053 Huynh, 1999, Remodeling of an acellular collagen graft into a physiologically responsive neovessel, Nat. Biotechnol., 17, 1083, 10.1038/15062 Hwang, 1989, Collagen shield enhancement of topical dexamethasone penetration, Arch. Ophthalmol., 107, 1375, 10.1001/archopht.1989.01070020445052 Jerome, 1992, Editorial: collagen-based, Biomaterials, 9, 137 Jeyanthi, 1990, In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels, Biomaterials, 11, 238, 10.1016/0142-9612(90)90004-A Jeyanthi, 1991, Solid tumour chemotherapy using implantable collagen-poly (HEMA) hydrogel containing 5-fluorouracil, J. Pharm. Pharmacol., 43, 60, 10.1111/j.2042-7158.1991.tb05453.x Katsube, 2000, Repair of articular cartilage defects with cultured chondrocytes in Atelocollagen gel. Comparison with cultured chondrocytes in suspension, Arch. Orthop. Trauma Surg., 120, 121, 10.1007/PL00021232 Kaufman, 1988, Collagen shield symposium, J. Cataract Refractive Surg., 14, 487, 10.1016/S0886-3350(88)80002-6 Kaufman, 1994, Collagen based drug delivery and artificial tears, J. Ocul. Pharmacol., 10, 17, 10.1089/jop.1994.10.17 Kemp, 2000, Tissue engineering and cell populated collagen matrices, 139, 287 Kimura, 2000, Bone-inductive efficacy of recombinant human bone morphogenetic protein-2 expressed in Escherichia coli: an experimental study in rat mandibular defects, Scand. J. Plast. Reconstr. Surg. Hand Surg., 34, 289, 10.1080/028443100750059057 Kobayashi, 2000, Clinical usefulness of crosslinked N-telopeptide of type I collagen as a bone metastatic marker in patients with prostate cancer: comparison with serum PICP, PINP and ICTP, Hinyokika, 46, 869 Kohmura, 1999, BNDF atelocollagen mini-pellet accelerates facial nerve regeneration, Brain Res., 849, 235, 10.1016/S0006-8993(99)02163-0 Koide, 1993, A new type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens, J. Biomed. Mater. Res., 27, 79, 10.1002/jbm.820270111 Kuwano, 1997, Effect of collagen cross-linking in collagen corneal shields on occular drug delivery, J. Pharmacol. Ther., 13, 31, 10.1089/jop.1997.13.31 Kuzuya, 1994, Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors, Exp. Cell Res., 215, 310, 10.1006/excr.1994.1347 Lam, 1999, The efficacy of collagen dermis membrane and fibrin on cultured epidermal graft using an athymic mouse model, Ann. Plast. Surg., 43, 523, 10.1097/00000637-199911000-00010 Leaders, 1973, New polymers in drug delivery, Ann. Ophthalmol., 5, 513 Lee, 1990, New directions in the optimization of ocular drug delivery, J. Ocul. Pharmacol., 6, 157, 10.1089/jop.1990.6.157 Lee, 1998, Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms, J. Biomed. Mater. Res., 42, 30, 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P Lefebvre, 1992, New artificial connective matrix-like structure made of elastin solubilized peptides and collagens: elaboration, biochemical and structural properties, Biomaterials, 13, 28, 10.1016/0142-9612(92)90091-2 Lefebvre, 1996, New preparation and microstructure of the EndoPatch elastin–collagen containing glycosaminoglycans, Biomaterials, 17, 1813, 10.1016/0142-9612(95)00346-0 Leipziger, 1985, Dermal wound repair: role of collagen matrix implants and synthetic polymer dressings, J. Am. Acad. Dermatol., 12, 409, 10.1016/S0190-9622(85)80004-9 Liang, 1992, Noncross-linked collagen discs and cross-linked collagen shields in the delivery of gentamicin to rabbit eyes, Invest. Ophthalmol. Vis. Sci., 33, 2194 Liu, 1993, Expression of human factor IX by microencapsulated recombinant fibroblasts, Hum. Gene Ther., 4, 291, 10.1089/hum.1993.4.3-291 Lucas, 1989, Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a collagenous delivery vehicle, J. Biomed. Mater. Res., 23, 23, 10.1002/jbm.820231306 Maeda, 1999, Microstructure and release characteristics of the minipellet, a collagen based drug delivery system for controlled release of protein drugs, J. Controlled. Rel., 62, 313, 10.1016/S0168-3659(99)00156-X Marks, 1991, Effects of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices, J. Biomed. Mater. Res., 25, 683, 10.1002/jbm.820250510 Marmer, 1988, Therapeutic and protective properties of the corneal shield, J. Cataract Refractive Surg., 14, 496, 10.1016/S0886-3350(88)80005-1 Marty, 1978, Nanoparticles-a new colloidal drug delivery system, Pharm. Acta. Helv., 53, 17 Matin-Chouly, 1999, In vitro evaluation of vascular permeability to contrast media using cultured endothelial cell monolayers, Invest. Radiol., 34, 663, 10.1097/00004424-199911000-00001 Matsuoka, 1988, Development of an interleukin-2 slow delivery system, Trans. Am. Soc. Artif. Intern. Organs, 34, 729 McPherson, 1986, An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants, J. Biomed. Mater. Res., 20, 93, 10.1002/jbm.820200109 Meaney, 1995, Mechanical properties of implantable biomaterials, Clin. Podiatr. Med. Surg., 12, 363, 10.1016/S0891-8422(23)00947-3 Mendicute, 1995, The use of collagen shields impregnated with amphotericin B to treat aspergillus keratomycosis, CLAO J., 21, 252 Milan, 1993, Collagen shields impregnated with gentamicin–dexamethason as a potential drug delivery device, Am.J. Ophthalmol., 116, 622, 10.1016/S0002-9394(14)73206-4 Miller, 1964, Clinical observation on use of an extrude collagen suture, Arch. Surg., 88, 167, 10.1001/archsurg.1964.01310200005002 Minabe, 1989, Subgingival administration of tetracycline on a collagen film, J. Periodontol., 60, 552, 10.1902/jop.1989.60.10.552 Minabe, 1989, Application of a local drug delivery system to periodontal therapy: I. Development of collagen preparations with immmobilized tetracycline, J. Periodontol., 60, 113, 10.1902/jop.1989.60.2.113 Miyata, 1971, Effects of ultraviolet irradiation on native and telopeptide-poor collagen, Biochem. Biophys. Acta., 229, 672 Miyata, 1992, Collagen engineering for biomaterial use, Clin. Mater., 9, 139, 10.1016/0267-6605(92)90093-9 Mondino, 1991, Collagen shields, Am. J. Ophthalmol., 112, 587, 10.1016/S0002-9394(14)76863-1 Moullier, 1993, Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts, Nat. Genet., 4, 154, 10.1038/ng0693-154 Moullier, 1993, Continuous systemic secretion of lysosomal enzyme by genetically-modified mouse skin fibroblasts, Transplantation, 56, 427, 10.1097/00007890-199308000-00034 Moullier, 1995, Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs, Nat. Med., 1, 353, 10.1038/nm0495-353 Muller, 2000, Solid lipid nanoparticles for controlled drug delivery-a review of the state of the art, Eur. J. Pharm. Biopharm., 50, 161, 10.1016/S0939-6411(00)00087-4 Mullins, 1996, Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons, Austr. New Zealand J. Ophthalmol., 24, 257, 10.1111/j.1442-9071.1996.tb01589.x Muniruzzaman, 1998, Complexation of basic fibroblast growth factor with gelatin, J. Biomater. Sci. Polym. Ed., 9, 459, 10.1163/156856298X00569 Murata, 1999, Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone, Int. J. Oral. Maxillofac. Surg., 28, 232, 10.1016/S0901-5027(99)80144-1 Murata, 2000, Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum, Clin. Oral Implants Res., 11, 289, 10.1034/j.1600-0501.2000.011004289.x Murray, 1990, Collagen shield heparin delivery for prevention of postoperative fibrin, Arch. Ophthalmol., 108, 104, 10.1001/archopht.1990.01070030110039 Nakagawa, 2000, Ultrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ectopic site, Oral Dis., 6, 172, 10.1111/j.1601-0825.2000.tb00329.x Narayani, 1994, Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres, J. Microencapsulation, 11, 69, 10.3109/02652049409040439 Nicholas, 1997, Denatured thiolated collagen. II. Crosslinking by oxidation, Biomaterials, 18, 815, 10.1016/S0142-9612(97)00003-3 Nimni, 1988, Molecular structures and functions of collagen, I, 1 Nimni, 1988, Bioprosthesis derived from crosslinked and chemically modified collagenous tissue, III, 1 O'Brien, 1988, Use of collagen corneal shields versus soft contact lenses to enhance penetration of topical tobramycin, J. Cataract Refractive. Surg., 14, 505, 10.1016/S0886-3350(88)80007-5 Ochiya, 1999, New Delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet, Nat. Med., 5, 707, 10.1038/9560 Orwin, 2000, In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix, Tissue Eng., 6, 307, 10.1089/107632700418038 Pachence, 1987, Collagen: its place in the medical device industry, Med. Device Diagn. Ind., 9, 49 Pajean, 1993, Effect of collagen on liposome permeability, Int. J. Pharm., 91, 209, 10.1016/0378-5173(93)90340-L Palmer, 1995, A corneal lens/shield system to promote postoperative corneal epithelial healing, J. Cataract Refractive. Surg., 21, 125, 10.1016/S0886-3350(13)80497-X Park, 2000, Type I atelocollagen grafting onto ozone-treated polyurethane films: cell attachment, proliferation, and collagen synthesis, J. Biomed. Mater. Res., 52, 669, 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.0.CO;2-U Peng, 1986, Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia, Invest. New Drugs, 4, 245, 10.1007/BF00179591 Petite, 1990, Use of the acyl azide method for crosslinking collagen rich tissues such as pericardium, J. Biomed. Mater. Res., 24, 179, 10.1002/jbm.820240205 Phinney, 1988, Collagen shield delivery of gentamicin and vancomycin, Arch. Ophthalmol., 106, 1599, 10.1001/archopht.1988.01060140767052 Piez, 1984, Molecular and aggregate structures of the collagens, 1 Pleyer, 1994, Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields, Curr. Eye Res., 13, 177, 10.3109/02713689408995775 Podos, 1972, Pilocarpine therapy with soft contact lenses, Am. J. Ophthalmol., 73, 336, 10.1016/0002-9394(72)90062-1 Poland, 1988, Clinical uses of collagen shields, J. Cataract Refractive. Surg., 14, 489, 10.1016/S0886-3350(88)80003-8 Ponticiello, 2000, Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy, J. Biomed. Mater. Res., 52, 246, 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W Prajapati, 2000, Mechanical loading regulates protease production by fibroblasts in three dimensional collagen substrates, Wound Repair Regen., 8, 226, 10.1046/j.1524-475x.2000.00226.x Ramachandran, 1965, Refinement of the structure of collagen, Biochim. Biophys. Acta., 109, 27, 314, 10.1016/0926-6585(65)90119-6 Rao, 1995, Recent Developments of Collagen-based materials for medical applications and drug delivery systems, J. Biomater. Sci., 7, 623 Rao, 1992, Effect of crosslinking agent on the release of an aqueous marker from liposomes sequestered in collagen and chitosan gels, J. Membr. Sci., 71, 161, 10.1016/0376-7388(92)85015-B Reddi, 2000, Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials, Tissue Eng., 6, 351, 10.1089/107632700418074 Reidy, 1990, The collagen shield: a new vehicle for delivery of cyclosporine A to the eye, Cornea, 9, 196, 10.1097/00003226-199007000-00003 Remacle, 1995, Treatment of vocal fold immobility by glutaraldehyde-crosslinked collagen injection: long term results, Ann. Otol. Rhinol. Laryngol., 104, 437, 10.1177/000348949510400604 Robin, 1990, The effect of collagen shields on rabbit corneal re-epithelization after chemical debridement, Invest. Ophthalmol. Vis. Sci., 31, 1294 Rosenthal, 1997, Collagen as matrix for neo-organ formation by gene-transfected fibroblasts, Anticancer Res., 17, 1179 Rossler, 1994, Effect of Collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro, Pharmazie, 49, 175 Rossler, 1995, Collagen microparticles: preparation and properties, J. Microencapsulation, 12, 49, 10.3109/02652049509051126 Royce, 1995, The enhancement of cellular infiltration and vascularization of a collagenous dermal implant in the rat by platelet-derived growth factor BB, J. Cermatol. Sci., 10, 42, 10.1016/0923-1811(95)93713-B Rubin, 1973, Collagen as a vehicle for drug delivery, J. Clin. Pharmacol., 13, 309 Ruderman, 1973, Prolonged resorption of collagen sponges: vapor-phase treatment with formaldehyde, J. Biomed. Mater. Res., 7, 263, 10.1002/jbm.820070213 Sahai, 1995, An injectable sustained release drug delivery system markedly enhances intratumoral retention of C14-fluorouracil in murine fibro sarcomas, Pharm. Res., 12, S227 Samuel, 1998, Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat public symphysis, J. Endocrinol., 159, 117, 10.1677/joe.0.1590117 Sastry, 1991, High performance biomaterials, 171 Sato, 1996, Microdialysis assessment of microfibrous collagen containing a p-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etopocide, Pharm. Res., 13, 1565, 10.1023/A:1016096016642 Sawusch, 1988, Use of collagen corneal shields in the treatment of bacterial keratitis, Am. J. Ophthalmol., 106, 279, 10.1016/0002-9394(88)90361-3 Sawusch, 1988, Collagen corneal shields enhance penetration of topical prednisolone acetate, J. Cataract Refractive. Surg., 14, 625 Scharfmann, 1991, Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants, Proc. Natl. Acad. Sci. USA, 88, 4626, 10.1073/pnas.88.11.4626 Schoen, 1992, Antimineralization treatments for bioprosthetic heart valves: assessment of efficacy and safety, J. Thorac. Cardiovasc. Surg., 104, 1285, 10.1016/S0022-5223(19)34619-7 Schwartz, 1990, Collagen shield delivery of amphotericin B, Am. J. Ophthalmol., 109, 701, 10.1016/S0002-9394(14)72439-0 Sekine, 2001, A new type of surgical adhesive made from porcine collagen and polyglutamic acid, J. Biomed. Mater. Res., 54, 305, 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B Sela, 2000, Retinoic acid enhances the effect of collagen on bone union, following induced non-union defect in guinea pig ulna, Inflamm. Res., 49, 679, 10.1007/s000110050646 Shaker, 1989, Effect of collagen shield on cat corneal epithelial wound healing, Invest. Ophthalmol. Vis. Sci., 30, 1565 Shantha, 1993, J. Bioact. Compatible Polym., 8, 142, 10.1177/088391159300800204 Shortliffe, 1989, Treatment of urinary incontinence by the periurethal implantation of glutaraldehyde crosslinked collagen, J. Urol., 141, 538, 10.1016/S0022-5347(17)40885-8 Sobolewski, 1995, Collagen, elastin and glycosaminoglycans in aortic aneurysms, Acta Biochimica. Polonica, 42, 301, 10.18388/abp.1995_4588 Stemberger, 1997, Local treatment of bone and soft tissue infections with the collagen gentamicin sponge, Eur. J. Surg., 578, 17 Stenzel, 1969, Collagen gels: design for vitreous replacement, Science, 164, 1282, 10.1126/science.164.3885.1282 Stompro, 1989, Attachment of peptide growth factors to implantable collagen, J. Surg. Res., 46, 413, 10.1016/0022-4804(89)90153-4 Suh, 2001, Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly l-lactic acid membrane, Biomaterials, 22, 219, 10.1016/S0142-9612(00)00177-0 Supp, 1999, Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice, Wound Repair Rege., 7, 226, 10.1046/j.1524-475X.1999.00226.x Suzuki, 2000, Long-term follow-up study of artificial dermis composed of outer silicone layer and inner collagen sponge, Br. J. Plast. Surg., 53, 659, 10.1054/bjps.2000.3426 Takaoka, 1988, Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein, Clin. Orthop., 234, 250, 10.1097/00003086-198809000-00044 Takenaka, 1986, New Formulations of bioactive materials, Pharm. Tech. Japan, 2, 1083 Tani, 1989, Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine supplement gene therapy, Blood, 74, 1274, 10.1182/blood.V74.4.1274.1274 Taravella, 1999, Collagen shield delivery of ofloxacin to the human eye, J. Cataract Refractive. Surg., 25, 562, 10.1016/S0886-3350(99)80056-X Thacharodi, 1996, Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations, Biomaterials, 17, 1307, 10.1016/0142-9612(96)88676-5 Timpl, 1984, Immunology of the collagens, 159 Trasciatti, 1998, In vitro effects of different formulations of bovine collagen on cultured human skin, Biomaterials, 19, 897, 10.1016/S0142-9612(97)00175-0 Traub, 1971, The chemistry and structure of collagen, 25, 245 Tu, 1993, Kinetic study of collagen fixation with polyepoxy fixatives, J. Biomed. Mater. Res., 27, 3, 10.1002/jbm.820270103 Uchio, 2000, Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gel, J. Biomed. Mater. Res., 50, 138, 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K Uitterlinden, 2001, Interaction between the vitamin D receptor gene and collagen type Ialpha 1 gene in susceptibility for fracture, J. Bone Miner. Res., 15, 379, 10.1359/jbmr.2001.16.2.379 Ulrich, 2001, Cross linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer, Arch. Gynecol. Obstet., 264, 186, 10.1007/s004040000105 Unterman, 1988, Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humour, J. Cataract Refractive. Surg., 14, 500, 10.1016/S0886-3350(88)80006-3 Van der Laan, 1991, Tee-plasma polymerized dermal sheep collagen for the repair of abdominal wall defects, Int. J. Artif. Organs, 14, 661, 10.1177/039139889101401010 Vaneerdeweg, 1998, Comparison between plain and gentamicin containing collagen sponges in infected peritoneal cavity in rats, Eur. J. Surg., 164, 617, 10.1080/110241598750005723 Vaneerdeweg, 2000, Effect of gentamicin-containing sponges on the healing of colonic anastomoses in a rat model of peritonitis, Eur. J. Surg., 166, 959, 10.1080/110241500447137 Vardaxis, 1996, Calcification of cross-linked collagen-elastin membrane implants in vivo and their proposed use in bone regeneration, Biomaterials, 17, 1489, 10.1016/0142-9612(96)89773-0 Wachol-Drewek, 1996, Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamycin, Biomaterials, 17, 1733, 10.1016/0142-9612(96)87654-X Wada, 1999, Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin, Circ. Res., 84, 166, 10.1161/01.RES.84.2.166 Waltman, 1970, Use of hydrophilic soft lenses to increase ocular penetration of topical drugs, Invest. Ophthalmol., 9, 250 Wang, 1978, Collagen-induced platelet aggregation and release, Biochim. Biophys. Acta., 544, 555, 10.1016/0304-4165(78)90330-6 Webster, 1984, Injectable collagen for augmentation of facial areas, Arch. Otolaryngol., 110, 652, 10.1001/archotol.1984.00800360024005 Wedge, 1992, Collagen shields: efficacy, safety and comfort in the treatment of human traumatic corneal abrasion and effect on vision in healthy eyes, Can. J. Ophthalmol., 27, 295 Weiner, 1985, Liposome-collagen gel matrix, A novel sustained drug delivery system, J. Pharm. Sci., 74, 922, 10.1002/jps.2600740903 Willey, 1991, Ocular acyclovir delivery by collagen discs: a mouse model to screen anti-viral agents, Curr. Eye, 10, 167, 10.3109/02713689109020374 Woolley, 1984, Mammalian collagenases, 119 Yamada, 1999, Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix, Scand. J. Plast. Reconstr. Surg. Hand Surg., 33, 147, 10.1080/02844319950159398 Yamahira, Y., Fujioka, K., Sato, S., Yoshido, N. 1991. Sustained release injections, Eur. Patent 84112313.6. Yang, 1999, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain, J. Control. Release, 59, 299, 10.1016/S0168-3659(99)00007-3 Yannas, 1990, Biologically active analogues of the extracellular matrix: artificial skin and nerves, Angew Chem. Int. Ed., 29, 20, 10.1002/anie.199000201 Yannas, 1989, Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin, Proc. Natl. Acad. Sci. USA, 86, 933, 10.1073/pnas.86.3.933